Impact of serum C-reactive protein elevation on the left ventricular spherical change and the development of mitral regurgitation after anterior acute myocardial infarction

Cardiology

Volumn 107, Issue 4, 2007, Pages 386-394

  Kohno, Takashi ^a   Anzai, Toshihisa ^a   Naito, Kotaro ^a   Ohno, Yohei ^a   Kaneko, Hidehiro ^a   Li, Hui Chong ^a   Sugano, Yasuo ^a   Maekawa, Yuichiro ^a   Iwanaga, Shiro ^a   Asakura, Yasushi ^a   Yoshikawa, Tsutomu ^a   Ogawa, Satoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Inflammation; Mitral valve; Remodeling

Indexed keywords

C REACTIVE PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COLOR ULTRASOUND FLOWMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE REMODELING; HOSPITAL READMISSION; HUMAN; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; UPREGULATION;

AGED; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; VENTRICULAR REMODELING;

EID: 34249016983     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099057     Document Type: Article

References (40)

1. Lamas GA, Mitchell GF, Flaker GC, Smith SC Jr, Gersh BJ, Basta L, Moye L, Braunwald E, Pfeffer MA: Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation 1997;96:827-833.
2. Feinberg MS, Schwammenthal E, Shlizerman L, Porter A, Hod H, Friemark D, Matezky S, Boyko V, Mandelzweig L, Vered Z, Behar S, Sagie A: Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction. Am J Cardiol 2000;86:903-907.
3. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ: Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-1764.
4. Pellizzon GG, Grines CL, Cox DA, Stuckey T, Tcheng JE, Garcia E, Guagliumi G, Turco M, Lansky AJ, Griffin JJ, Cohen DJ, Aymong E, Mehran R, O'Neill WW, Stone GW: Importance of mitral regurgitation in patients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 2004;43:1368-1374.
5. Nešković AN, Marinković J, Bojic M, Popović AD: Early predictors of mitral regurgitation after acute myocardial infarction. Am J Cardiol 1999;84:329-332, A328.
6. Messas E, Guerrero JL, Handschumacher MD, Chow CM, Sullivan S, Schwammenthal E, Levine RA: Paradoxic decrease in ischemic mitral regurgitation with papillary muscle dysfunction: insights from three-dimensional and contrast echocardiography with strain rate measurement. Circulation 2001;104:1952-1957.
7. Golia G, Anselmi M, Rossi A, Cicoira MA, Tinto M, Marino P, Zardini P: Relationship between mitral regurgitation and myocardial viability after acute myocardial infarction: their impact on prognosis. Int J Cardiol 2001;78:81-90.
8. Uemura T, Otsuji Y, Nakashiki K, Yoshifuku S, Maki Y, Yu B, Mizukami N, Kuwahara E, Hamasaki S, Biro S, Kisanuki A, Minagoe S, Levine RA, Tei C: Papillary muscle dysfunction attenuates ischemic mitral regurgitation in patients with localized basal inferior left ventricular remodeling: insights from tissue Doppler strain imaging. J Am Coll Cardiol 2005;46:113-119.
9. Otsuji Y, Handschumacher MD, Liel-Cohen N, Tanabe H, Jiang L, Schwammenthal E, Guerrero JL, Nicholls LA, Vlahakes GJ, Levine RA: Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol 2001;37:641-648.
10. Guy TS, Moainie SL, Gorman JH 3rd, Jackson BM, Plappert T, Enomoto Y, St John-Sutton MG, Edmunds LH Jr, Gorman RC: Prevention of ischemic mitral regurgitation does not influence the outcome of remodeling after posterolateral myocardial infarction. J Am Coll Cardiol 2004;43:377-383.
11. Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S: Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992;20:1594-1598.
12. Sabbah HN, Kono T, Stein PD, Mancini GB, Goldstein S: Left ventricular shape changes during the course of evolving heart failure. Am J Physiol 1992;263:H266-H270.
13. Mannaerts HF, van der Heide JA, Kamp O, Stoel MG, Twisk J, Visser CA: Early identification of left ventricular remodelling after myocardial infarction, assessed by transthoracic 3D echocardiography. Eur Heart J 2004;25:680-687.
14. Bogaert J, Bosmans H, Maes A, Suetens P, Marchal G, Rademakers FE: Remote myocardial dysfunction after acute anterior myocardial infarction: impact of left ventricular shape on regional function: a magnetic resonance myocardial tagging study. J Am Coll Cardiol 2000;35:1525-1534.
15. Hammerman H, Kloner RA, Hale F, Schoen FJ, Braunwald E: Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation and ventricular function. Circulation 1983;68:446-453.
16. Roberts R, DeMello V, Sobel BE: Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 1976;53:I204-I206.
17. Arstall MA, Sawyer DB, Fukazawa R, Kelly RA: Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 1999;85:829-840.
18. MacLellan WR, Schneider MD: Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 1997;81:137-144.
19. Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, DeMayo FJ, Spinale FG, Mann DL: Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2001;104:826-831.
20. Li YY, Feng YQ, Kadokami T, McTiernan CF, Draviam R, Watkins SC, Feldman AM: Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by antitumor necrosis factor alpha therapy. Proc Natl Acad Sci USA 2000;97:12746-12751.
21. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S, Mitamura H, Ogawa S: Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 2002;39:241-246.
22. Nian M, Lee P, Khaper N, Liu P: Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004;94:1543-1553.
23. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, Ogawa S: C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997;96:778-784.
24. Mahara K, Anzai T, Yoshikawa T, Maekawa Y, Okabe T, Asakura Y, Satoh T, Mitamura H, Suzuki M, Murayama A, Ogawa S: Aging adversely affects postinfarction inflammatory response and early left ventricular remodeling after reperfused acute anterior myocardial infarction. Cardiology 2005;105:67-74.
25. Van Dantzig JM, Delemarre BJ, Koster RW, Bot H, Visser CA: Pathogenesis of mitral regurgitation in acute myocardial infarction: importance of changes in left ventricular shape and regional function. Am Heart J 1996;131:865-871.
26. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463.
27. Wong SP, French JK, Lydon AM, Manda SO, Gao W, Ashton NG, White HD: Relation of left ventricular sphericity to 10-year survival after acute myocardial infarction. Am J Cardiol 2004;94:1270-1275.
28. Sabbah HN, Rosman H, Kono T, Alam M, Khaja F, Goldstein S: On the mechanism of functional mitral regurgitation. Am J Cardiol 1993;72:1074-1076.
29. Mulieri LA, Tischler MD, Martin BJ, Leavitt BJ, Ittleman FP, Alpert NR, LeWinter MM: Regional differences in the force-frequency relation of human left ventricular myocardium in mitral regurgitation: implications for ventricular shape. Am J Physiol Heart Circ Physiol 2005;288:H2185-H2191.
30. Carabello BA, Nolan SP, McGuire LB: Assessment of preoperative left ventricular function in patients with mitral regurgitation: value of the end-systolic wall stress-end-systolic volume ratio. Circulation 1981;64:1212-1217.
31. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S: Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 1998;98:149-156.
32. Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, Kawai T, Shimada K: Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 1992;24:579-584.
33. Pietila K, Harmoinen A, Hermens W, Simoons ML, Van de Werf F, Verstraete M: Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart J 1993;14:915-919.
34. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-1172.
35. Weisfeldt M: Aging, changes in the cardiovascular system, and responses to stress. Am J Hypertens 1998;11:41S-45S.
36. Kumanohoso T, Otsuji Y, Yoshifuku S, Matsukida K, Koriyama C, Kisanuki A, Minagoe S, Levine RA, Tei C: Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction. J Thorac Cardiovasc Surg 2003;125:135-143.
37. Leor J, Feinberg MS, Vered Z, Hod H, Kaplinsky E, Goldbourt U, Truman S, Motro M: Effect of thrombolytic therapy on the evolution of significant mitral regurgitation in patients with a first inferior myocardial infarction. J Am Coll Cardiol 1993;21:1661-1666.
38. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ: Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation 2000;102:1400-1406.
39. Anzai T, Yoshikawa T, Takahashi T, Maekawa Y, Okabe T, Asakura Y, Satoh T, Mitamura H, Ogawa S: Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable shortterm prognosis after acute myocardial infarction. Cardiology 2003;99:47-53.
40. Enriquez-Sarano M, Tajik AJ, Bailey KR, Seward JB: Color flow imaging compared with quantitative Doppler assessment of severity of mitral regurgitation: influence of eccentricity of jet and mechanism of regurgitation. J Am Coll Cardiol 1993;21:1211-1219.